TrialCancer2010

Phase 2 trial of talampanel, a glutamate receptor inhibitor, for adults with recurrent malignant gliomas.

Fabio M Iwamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.